Skip to content

Cardiac Troponin I, Serum (High Sensitivity)

Published: August 9, 2026Updated: August 16, 2026

This test measures a protein released when your heart muscle is damaged, often due to a heart attack or other heart stress. It helps doctors assess whether you’re at risk for serious heart problems.

Quick summary

["This test can detect early heart damage, even before symptoms appear."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
102080-9
Short code
CARTBLD
Synonyms
CAR-T cell BPU
Category
chemistry
Sample
whole-blood
Container
Sterile, closed-system cell product bag (e.g., CryoStore or equivalent cryogenic storage bag) or manufacturer-supplied infusion bag; transported in validated temperature-controlled shipper
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
0–120 years
Method
Flow cytometry with immunophenotyping using CD3, CD4, CD8, and CAR-specific marker antibodies; may include quantitative PCR (qPCR) for CAR transgene detection and viability assessment via 7-AAD or trypan blue exclusion
CPT
0537T (Chimeric antigen receptor T-cell (CAR-T) therapy; collection, processing, and preparation of cells for administration); additional flow cytometry codes (88184, 88185) may apply for cell counting
SNOMED
116859006 (Transfusion of blood product) and 118757001 (Cellular therapy procedure); product-specific SNOMED codes vary by CAR-T construct
Specimen volume
Variable; typically the entire CAR-T cell product bag volume (10-100 mL for fresh products; cryopreserved bags reconstituted per protocol). Minimum sample volume for quality testing: 1-5 mL aliquot.
Stability
Fresh product: stable at 2-8°C for up to 72 hours post-manufacture (product-specific). Cryopreserved product: stable at ≤-150°C (vapor phase liquid nitrogen) for long-term storage. Post-thaw viability decreases over time; infuse within manufacturer-specified window (typically 2-4 hours at room temperature).
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–72 hours
Order
routine

Why This Test Matters

Cardiac troponin I is a key marker for heart injury. When heart cells are damaged—such as during a heart attack—their contents, including troponin I, leak into the bloodstream. Detecting elevated levels can signal acute myocardial infarction (heart attack) or other conditions like unstable angina, myocarditis, or severe heart strain. High-sensitivity testing improves early detection, allowing for quicker medical intervention if needed.

What to Expect Before the Test

No special preparation is needed for this test. You’ll have a small needle inserted into your arm or hand to draw a blood sample. The process is quick and usually painless. If you’re on blood thinners, let your healthcare provider know before the test.

How the Test Works

Blood is drawn and sent to a lab, where it’s analyzed using a highly sensitive immunoassay method. This test measures tiny amounts of troponin I in your serum, even when levels are just slightly elevated. Results are compared to a reference range to determine if your levels are within normal limits or elevated.

What the Results Mean

If your troponin I levels are normal, it suggests your heart is functioning well without recent damage. If levels are elevated, your doctor may investigate further to rule out heart issues like a heart attack, heart failure, or other cardiac stress. Follow-up tests or imaging may be needed to understand the cause.

Reference range

Product release criteria are defined per manufacturing specification; minimum acceptable CAR-T cell dose, viability ≥70%, and transduction efficiency per lot release certificate. Reference ranges not applicable for blood product unit testing as each product batch has individualized release criteria.N/A

Specimen: whole-blood

Patient preparation is not applicable as testing is performed on the manufactured CAR-T cell blood product unit, not the patient directly. Patient apheresis collection prior to manufacturing requires standard cell therapy protocols.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

hs-cTnI

Frequently asked questions

What causes elevated troponin I levels?
Elevated troponin I can be caused by heart attacks, severe heart strain (such as from heart failure or myocarditis), or other conditions like kidney disease, severe infections, or certain medications. It’s important to discuss your symptoms and medical history with your doctor to determine the best next steps.
How soon after a heart attack will this test show results?
Troponin I levels begin to rise within a few hours after heart damage occurs and peak around 1–2 days. They may stay elevated for days or weeks, depending on the severity of the injury. Your doctor will interpret results in the context of your symptoms and timeline.
Can false-positive or false-negative results happen?
Yes, rare false positives can occur due to other conditions like severe muscle injury or kidney problems. False negatives are less common but may happen if the test is taken too early after heart damage. Your doctor will consider all factors, including timing of the test and your medical history, when interpreting results.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy